VANGUARD GROUP INC - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 33 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$705,208
+28.0%
373,126
-0.5%
0.00%
Q2 2023$550,994
-24.6%
374,8260.0%0.00%
Q1 2023$730,911
-13.3%
374,8260.0%0.00%
Q4 2022$843,359
-6.6%
374,826
+0.0%
0.00%
Q3 2022$903,000
+16.1%
374,6910.0%0.00%
Q2 2022$778,000
-27.0%
374,691
-0.9%
0.00%
Q1 2022$1,066,000
-41.6%
377,984
-3.4%
0.00%
Q4 2021$1,826,000
+73.9%
391,179
-0.1%
0.00%
Q3 2021$1,050,000
-5.8%
391,5960.0%0.00%
Q2 2021$1,115,000
-6.0%
391,5960.0%0.00%
Q1 2021$1,186,000
+2.7%
391,5960.0%0.00%
Q4 2020$1,155,000
-8.1%
391,596
-0.0%
0.00%
Q3 2020$1,257,000
-3.7%
391,6950.0%0.00%
Q2 2020$1,305,000
-8.2%
391,6950.0%0.00%
Q1 2020$1,422,000
-29.5%
391,6950.0%0.00%
Q4 2019$2,018,000
-13.1%
391,695
+0.0%
0.00%
Q3 2019$2,322,000
-1.1%
391,596
+6.2%
0.00%
Q2 2019$2,349,000
+9.7%
368,7250.0%0.00%
Q1 2019$2,142,000
+8.2%
368,725
+17.4%
0.00%
Q4 2018$1,979,000
+10.5%
314,024
+0.1%
0.00%
Q3 2018$1,791,000
-6.9%
313,7640.0%0.00%
Q2 2018$1,923,000
-8.3%
313,7640.0%0.00%
Q1 2018$2,096,000
-10.7%
313,764
-0.8%
0.00%
Q4 2017$2,347,000
+9.7%
316,237
+4.4%
0.00%
Q3 2017$2,139,000
+1.3%
302,950
+1.4%
0.00%
Q2 2017$2,111,000
+2.3%
298,635
+0.4%
0.00%
Q1 2017$2,064,000
+26.2%
297,4550.0%0.00%
Q4 2016$1,636,000
+9.6%
297,455
-0.2%
0.00%
Q3 2016$1,493,000
+11.7%
298,123
+0.3%
0.00%
Q2 2016$1,337,000
+1.1%
297,223
+0.9%
0.00%
Q1 2016$1,323,000
-13.1%
294,623
+1.7%
0.00%
Q4 2015$1,523,000
-99.0%
289,620
-94.2%
0.00%
-100.0%
Q3 2015$159,789,000
+7767.5%
4,988,582
+1655.8%
0.01%
Q2 2015$2,031,000
+6.8%
284,120
-0.5%
0.00%
Q1 2015$1,902,000
+13.4%
285,546
+2.2%
0.00%
Q4 2014$1,677,000
+25.0%
279,432
+2.8%
0.00%
Q3 2014$1,342,000
+9.7%
271,7320.0%0.00%
Q2 2014$1,223,000
+1.2%
271,732
+1.1%
0.00%
Q1 2014$1,209,000
-11.7%
268,832
+0.4%
0.00%
Q4 2013$1,369,000
+12.9%
267,8320.0%0.00%
Q3 2013$1,213,000
-11.4%
267,8320.0%0.00%
Q2 2013$1,369,000267,8320.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q3 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 896,170$4,615,0003.22%
Ariel Investments 1,010,220$5,203,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,000$942,0000.01%
Anfield Capital Management, LLC 4,530$23,0000.01%
Financial Gravity Asset Management, Inc. 2,000$10,0000.01%
Oakworth Capital, Inc. 3,052$16,0000.00%
BAILARD, INC. 11,816$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 860,319$4,431,0000.00%
Renaissance Technologies 469,338$2,417,0000.00%
ACADIAN ASSET MANAGEMENT LLC 98,192$506,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders